Literature DB >> 2128088

Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production.

V Chopra1, S K Tyring, L Johnson, J D Fine.   

Abstract

Peripheral blood mononuclear cells (PBMC) from patients with severe forms of inherited epidermolysis bullosa (EB) are deficient in functions governing cellular immunity. Very low levels of interferon-gamma (IFN-gamma), interleukin-1 (IL-1), and interleukin-2 (IL-2) were produced in vitro by PBMC from patients with severe forms of EB (recessive dystrophic and dominant dystrophic) as compared to sex- and age-matched controls. Lymphokine production by PBMC from patients with junctional EB was somewhat greater than that from patients with dystrophic forms of EB but was significantly less than that from controls. The production of interferon-alpha was not found to be altered in the severe forms of EB. The PBMC from dystrophic types of EB were also deficient in production of tumor necrosis factors (TNF-alpha and TNF-beta). The degree of the reduction in immune functions was directly related to the severity of skin involvement, with recessive dystrophic EB having the lowest level of cytokine production. This reduced production of monokines and lymphokines may be partially responsible for the progression of cutaneous infections to septicemia and for the metastasis of cutaneous squamous cell carcinomas in patients with severe forms of dystrophic EB.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128088     DOI: 10.1007/bf00917477

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

Review 1.  Epidermolysis bullosa dystrophica with epidermal neoplasms.

Authors:  W B Reed; J College; M J Francis; H Zachariae; F Mohs; M A Sher; I B Sneddon
Journal:  Arch Dermatol       Date:  1974-12

2.  Nutrition, immunity, and infection: present knowledge and future directions.

Authors:  R K Chandra
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

Review 5.  Epidermolysis bullosa: a review.

Authors:  T W Cooper; E A Bauer
Journal:  Pediatr Dermatol       Date:  1984-01       Impact factor: 1.588

6.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

Authors:  G V Quinnan; N Kirmani; A H Rook; J F Manischewitz; L Jackson; G Moreschi; G W Santos; R Saral; W H Burns
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

7.  Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes.

Authors:  M P Langford; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

8.  Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa.

Authors:  S K Tyring; V Chopra; L Johnson; J D Fine
Journal:  Arch Dermatol       Date:  1989-06

9.  Determination of human leukocyte populations involved in production of interferons alpha and gamma.

Authors:  M Wiranowska-Stewart; W E Stewart
Journal:  J Interferon Res       Date:  1981-02

10.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more
  4 in total

1.  Altered cytokine production in black patients with keloids.

Authors:  R L McCauley; V Chopra; Y Y Li; D N Herndon; M C Robson
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

2.  Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.

Authors:  Susanna Esposito; Sophie Guez; Annalisa Orenti; Gianluca Tadini; Giulietta Scuvera; Laura Corti; Alessia Scala; Elia Biganzoli; Emilio Berti; Nicola Principi
Journal:  Int J Mol Sci       Date:  2016-09-24       Impact factor: 5.923

Review 3.  Pre-Cancerous Lesions in the Oral and Maxillofacial Region: A Literature Review with Special Focus on Etiopathogenesis.

Authors:  Soussan Irani
Journal:  Iran J Pathol       Date:  2016

4.  Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa.

Authors:  Giuseppina Annicchiarico; Maria Grazia Morgese; Susanna Esposito; Giuseppe Lopalco; Michele Lattarulo; Marilina Tampoia; Domenico Bonamonte; Luigia Brunetti; Antonio Vitale; Giovanni Lapadula; Luca Cantarini; Florenzo Iannone
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.